Abstract:Background . Papillary thyroid carcinoma (PTC) is the commonest thyroid malignancy originating from the follicle cells in the thyroid. Despite a good overall prognosis, certain high-risk cases as in those with lymph node metastasis (LNM) have progressive disease and poorer prognosis. MicroRNAs are a class of non-protein-coding, 19-24 nucleotides single-stranded RNAs which regulate gene expression and these molecules have been shown to play a role in LNM. The integrated analysis of miRNAs and gene expression profiles together with transcription factors (TFs) has been shown to improve the identification of functional miRNA-target gene-TF relationships, providing a more complete view of molecular events underlying metastasis process. Objectives . We reanalyzed The Cancer Genome Atlas (TCGA) datasets on PTC to identify differentially expressed miRNAs/genes in PTC patients with LNM-positive (LNM-P) versus lymph node negative (LNN) PTC patients and to investigate the miRNA-gene-TF regulatory circuit that regulate LNM in PTC. Results . PTC patients with LNM (PTC LNM-P) have a significantly shorter disease-free survival rate compared to PTC patients without LNM (PTC LNN) (Log-rank Mantel Cox test, p = 0.0049). We identified 181 significantly differentially expressed miRNAs in PTC LNM-P versus PTC LNN; 110 were upregulated and 71 were downregulated. The five topmost deregulated miRNAs were hsa-miR-146b, hsa-miR-375, hsa-miR-31, hsa-miR-7-2 and hsa-miR-204. In addition, 395 miRNAs were differentially expressed between PTC LNM-P and normal thyroid while 400 miRNAs were differentially expressed between PTC LNN and normal thyroid. We found four significant enrichment pathways potentially involved in metastasis to the lymph nodes, namely oxidative phosphorylation (OxPhos), cell adhesion molecules (CAMs), leukocyte transendothelial migration and cytokine--cytokine receptor interaction. OxPhos was the most significantly perturbed pathway ( p = 4.70E−06) involving downregulation of 90 OxPhos-related genes. Significant interaction of hsa-miR-301b with HLF, HIF and REL/NFkB transcription factors were identified exclusively in PTC LNM-P versus PTC LNN. Conclusion . We found evidence of five miRNAs differentially expressed in PTC LNM-P. Alteration in OxPhos pathway could be the central event in metastasis to the lymph node in PTC. We postulate that hsa-miR-301b might be involved in regulating LNM in PTC via interactions with HLF, HIF and REL/NFkB. To the best of our knowledge, the roles of these TFs have been studied in PTC but the precise role of this miRNA with these TFs in LNM in PTC has not been investigated.

Preliminary Screening and Analysis of Metastasis-Related Lncrna and Co-Expressed Papillary Thyroid Carcinoma Mrna.

Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer

Expression Profile And Clinical Significance Of Micrornas In Papillary Thyroid Carcinoma

Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma

Transcriptome Analysis Identified 2 New Lncrnas Associated with the Metastasis of Papillary Thyroid Carcinoma.

Construction and analysis of an aberrant lncRNA-miRNA-mRNA network associated with papillary thyroid cancer

Long Noncoding RNA Are Aberrantly Expressed in Human Papillary Thyroid Carcinoma

Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning

Microarray Analysis of Lncrnas and Mrnas Co-Expression Network and Lncrna Function As Cerna in Papillary Thyroid Carcinoma

Screening and Bioinformatics Analysis of Thyroid Papillary Carcinoma Related Genes and MicroRNAs

The Long Non-Coding RNA ENST00000489676 Influences Papillary Thyroid Cancer Cell Proliferation and Invasion Through Regulating MiR-922.

Integrated Analysis of Long Noncoding RNA Interactions Reveals the Potential Role in Progression of Human Papillary Thyroid Cancer.

Cervical carcinoma high-expressed long non-coding RNA 1 promotes papillary thyroid carcinoma cell proliferation and invasion

Identification of Potential LncRNAs As Papillary Thyroid Carcinoma Biomarkers Based on Integrated Bioinformatics Analysis Using TCGA and RNA Sequencing Data

Molecular Characterization of Papillary Thyroid Carcinoma: a Potential Three-Lncrna Prognostic Signature.

Transcriptomic Signature Associated with Carcinogenesis and Aggressiveness of Papillary Thyroid Carcinoma

Identification of Long Noncoding RNAs Associated With the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated With Hashimoto’s Thyroiditis

LncRNA SNHG12 Promotes the Proliferation and Metastasis of Papillary Thyroid Carcinoma Cells Through Regulating Wnt/β-Catenin Signaling Pathway.

A Novel Lncrna N384546 Promotes Thyroid Papillary Cancer Progression and Metastasis by Acting As a Competing Endogenous RNA of Mir-145-5p to Regulate AKT3

Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis